Rational Design and In-Silico Evaluation of a Multi-Epitope Vaccine Targeting Human Glypican-3 (GPC3) for Hepatocellular Carcinoma Immunotherapy. VER. 2025;8(10s):203-216. Accessed April 8, 2026. https://verjournal.com/index.php/ver/article/view/812